Concepedia

Franklin Otu

FO

Statistics

Publications

3

Citations

191

H-Index

3

Active since

2005

Affiliations

Merck Canada Inc. (Canada)(Current)

Franklin Otu is an author at Merck Canada Inc. (Canada) specializing in asthma, pharmacotherapy, and animal models.

Top concepts

Publications per year

2005–2007

3

Publications

3

Quantitative Measurement of Changes in Amyloid-β(40) in the Rat Brain and Cerebrospinal Fluid following Treatment with the γ-Secretase Inhibitor LY-411575 [N2-[(2 S)-2-(3,5-Difluorophenyl)-2-hydroxyethanoyl]-N1-[(7 S)-5-methyl-6-oxo-6,7-dihydro-5 H-dibenzo[b,d]azepin-7-yl]-l-alaninamide]

Jonathan D. Best, Mark T. Jay, Franklin Otu et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 98 citations

In Vivo Characterization of Aβ(40) Changes in Brain and Cerebrospinal Fluid Using the Novel γ-Secretase Inhibitor N-[cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) in the Rat

Jonathan D. Best, Mark T. Jay, Franklin Otu et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 63 citations

L-454,560, a potent and selective PDE4 inhibitor with in vivo efficacy in animal models of asthma and cognition

Zheng Huang, Rebecca Dias, Tom R. Jones et al. · Biochemical Pharmacology · 2007 · 30 citations

, , +10

1–3 of 3